Depression and anxiety, the two most common mental health conditions, cost the global economy US$1 trillion each year and the World Health Organization has called for a transformation in global mental health care.
The PRISM Emerging Mental Health Index tracks small and micro-cap stocks that are contributing to advancing mental health care.
| PRISM Emerging Mental Health IndexInception Date of 1/2/2024 at $100.00 | % Change (Daily) | Current Index Value | % Change (Inception) | |||||
|---|---|---|---|---|---|---|---|---|
| -0.1% | $66.90 | -33.1% | ||||||
| Index Components | Ticker | Current Price | % Daily Change | Volume (1,000s) | Average Volume (1,000s) | Market Cap (Millions) | 1/2/2024 Price | % Change Since Inception 1/2/2024 |
| Reviva Pharmaceuticals Holdings, Inc. | RVPH | $1.78 | 8.537% | 4,205 | 1,888 | $83 | $5.31 | -66.5% |
| Seelos Therapeutics, Inc. | SEEL | $0.37 | -31.494% | 29 | 484 | $0 | $1.38 | -73.2% |
| Talkspace, Inc. | TALK | $3.02 | 0.667% | 724 | 2,026 | $510 | $2.38 | 26.9% |
| ABVC BioPharma, Inc. | ABVC | $0.51 | -3.774% | 23 | 253 | $7 | $1.20 | -57.5% |
| Bionomics Limited | BNOX | $0.25 | 4.587% | 906 | 9,740 | $789 | $1.35 | -81.3% |
| Sage Therapeutics, Inc. | SAGE | $5.48 | 0.735% | 605 | 924 | $335 | $22.48 | -75.6% |
| VistaGen Therapeutics, Inc. | VTGN | $2.55 | -0.778% | 251 | 241 | $71 | $5.15 | -50.5% |
| Alzamend Neuro, Inc. | ALZN | $1.19 | 3.478% | 42 | 214 | $6 | $0.92 | 29.3% |
| BioXcel Therapeutics, Inc. | BTAI | $0.35 | 1.357% | 412 | 617 | $17 | $2.93 | -88.0% |
| Cingulate Inc. | CING | $4.86 | 2.101% | 149 | 135 | $16 | $6.72 | -27.7% |
| BrainsWay Ltd. | BWAY | $9.35 | 2.186% | 40 | 91 | $176 | $7.22 | 29.5% |
| Anavex Life Sciences Corp. | AVXL | $10.87 | -2.773% | 2,862 | 1,312 | $922 | $6.05 | 79.8% |
| Vanda Pharmaceuticals Inc. | VNDA | $4.83 | 3.205% | 292 | 657 | $282 | $4.52 | 6.9% |
| Numinus Wellness Inc. | NUMIF | $0.03 | 0% | 62 | 230 | $8 | $0.08 | -67.9% |
| NRx Pharmaceuticals, Inc. | NRXP | $1.57 | 10.563% | 1,003 | 196 | $19 | $4.99 | -68.5% |
| ACADIA Pharmaceuticals Inc. | ACAD | $17.07 | -0.582% | 318 | 1,508 | $2,840 | $30.86 | -44.7% |
